headache relief extra strength
Generic: acetaminophen, aspirin and caffeine
Labeler: chain drug marketing association incDrug Facts
Product Profile
Brand Name
headache relief extra strength
Generic Name
acetaminophen, aspirin and caffeine
Labeler
chain drug marketing association inc
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63868-485
Product ID
63868-485_db6c7572-59e0-4734-bfd6-1117dad5dd1b
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Marketing Start
1992-11-17
Marketing End
2027-03-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63868485
Hyphenated Format
63868-485
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
headache relief extra strength (source: ndc)
Generic Name
acetaminophen, aspirin and caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 1 BOTTLE, PLASTIC in 1 CARTON (63868-485-01) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 1 BOTTLE, PLASTIC in 1 CARTON (63868-485-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 1 BOTTLE, PLASTIC in 1 CARTON (63868-485-50) / 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Packages (3)
63868-485-01
1 BOTTLE, PLASTIC in 1 CARTON (63868-485-01) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
63868-485-24
1 BOTTLE, PLASTIC in 1 CARTON (63868-485-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
63868-485-50
1 BOTTLE, PLASTIC in 1 CARTON (63868-485-50) / 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "db6c7572-59e0-4734-bfd6-1117dad5dd1b", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0635515946132"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["4005f8dd-3050-4590-8703-6997444e8df3"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-485-01) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "63868-485-01", "marketing_end_date": "20270331", "marketing_start_date": "19921117"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-485-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "63868-485-24", "marketing_end_date": "20270331", "marketing_start_date": "19921117"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-485-50) / 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "63868-485-50", "marketing_end_date": "20270331", "marketing_start_date": "19921117"}], "brand_name": "Headache Relief Extra Strength", "product_id": "63868-485_db6c7572-59e0-4734-bfd6-1117dad5dd1b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "63868-485", "generic_name": "Acetaminophen, Aspirin and caffeine", "labeler_name": "CHAIN DRUG MARKETING ASSOCIATION INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Headache Relief", "brand_name_suffix": "Extra Strength", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20270331", "marketing_start_date": "19921117"}